Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for non-exclusive rebate agreements for the active ingredient Ranibizumab in Erfurt, Germany, issued by AOK PLUS - Health Insurance for Saxony and Thuringia. The contract will be established through an Open-House model. Submission deadline: December 31, 2027.
Scope Of Work: The tender involves establishing non-exclusive rebate agreements for the drug Ranibizumab (10 mg/ml injection solution) under § 130a Abs. 8 SGB V. The contract operates under an Open-House model, allowing all interested pharmaceutical companies to participate during the specified period, provided they meet eligibility requirements. The quantities purchased will depend on demand, physician prescribing behavior, and pharmacy stock management, with no minimum purchase guarantees. Interested companies must apply for access to the participation documents via the German Procurement Portal (DTVP) and maintain confidentiality regarding the content of the agreements. The rebate agreements will terminate by December 31, 2027, unless ended earlier by the issuer.
Qualification Criterion: Bidders must be pharmaceutical companies that meet the participation requirements outlined in the documents available on the DTVP. They must submit applications electronically through the procurement portal. Confidentiality regarding the rebate agreement details is mandatory, and any unauthorized disclosure requires prior written consent from the issuer. All submitted documents must be securely destroyed if the company decides not to participate. The deadline for initial applications is December 2, 2026, with subsequent deadlines available in the project room.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Operation of a Dynamic Procurement System for Laboratory Consumables. | Germany | 152653979 | 02 Jan 2027 |
| Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ustekinumab from January 1, 2027 | Germany | 152653877 | 10 Aug 2028 |
| Open House Biologics Discount Agreements 2026-09 - Etanercept | Germany | 152653671 | 31 Dec 2026 |
| Delivery of Cleaning Products, Anker Facilities, Gu Etc., Government of Lower Bavaria | Germany | 152653374 | 17 Dec 2026 |
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Tacrolimus (Atc: D11ah01). | Germany | 152653349 | 27 Oct 2028 |